BIM
AMAG

BlackRock Investment Management’s AMAG Pharmaceuticals AMAG Stock Holding History

BlackRock Investment Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$6.47M Buy
185,963
+30,812
+20% +$921K 0.01% 1406
2016
Q3 		$3.8M Buy
155,151
+1,661
+1% +$41.5K ﹤0.01% 1677
2016
Q2 		$3.67M Buy
153,490
+17,113
+13% +$392K ﹤0.01% 1651
2016
Q1 		$3.19M Buy
136,377
+37,222
+38% +$883K ﹤0.01% 1680
2015
Q4 		$2.99M Buy
99,155
+39,996
+68% +$1.29M ﹤0.01% 1784
2015
Q3 		$2.35M Hold
59,159
– – ﹤0.01% 1956
2015
Q2 		$4.09M Sell
59,159
-6,009
-9% -$378K 0.01% 1658
2015
Q1 		$3.56M Sell
65,168
-1,069
-2% -$51K ﹤0.01% 1631
2014
Q4 		$2.82M Sell
66,237
-941
-1% -$34K ﹤0.01% 1773
2014
Q3 		$2.14M Buy
67,178
+605
+0.9% +$12.9K ﹤0.01% 1951
2014
Q2 		$1.38M Buy
66,573
+6,738
+11% +$125K ﹤0.01% 2367
2014
Q1 		$1.16M Buy
59,835
+612
+1% +$13K ﹤0.01% 2409
2013
Q4 		$1.44M Sell
59,223
-1,822
-3% -$42.9K ﹤0.01% 2246
2013
Q3 		$1.31M Buy
61,045
+3,394
+6% +$80.2K ﹤0.01% 2251
2013
Q2 		$1.28M Buy
+57,651
New +$1.27M ﹤0.01% 2186

Other funds holding AMAG

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock Investment Management's AMAG Position: Q4 2016 in Review

BlackRock Investment Management increased its AMAG Pharmaceuticals (AMAG) stake by 20% in Q4 2016, buying an estimated $921K and bringing the position to 185,963 shares worth $6.47M. The position accounts for 0.01% of the portfolio, ranked #1406.

BlackRock Investment Management first reported a position in AMAG in Q2 2013 and has held it in 15 quarters since. 206 funds tracked by Wall St. Rank hold AMAG as of Q4 2016.

  • BlackRock Investment Management held 185,963 shares of AMAG Pharmaceuticals worth $6.47M as of Q4 2016.
  • BlackRock Investment Management bought 30,812 AMAG Pharmaceuticals shares in Q4 2016, an estimated $921K.
  • AMAG Pharmaceuticals made up 0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1406 holding.
  • BlackRock Investment Management first reported a position in AMAG Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • 206 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.